Cargando…
Etanercept in the treatment of recalcitrant enteropathic arthritis: a case report
INTRODUCTION: Enteropathic arthritis is one of the recognized extraintestinal manifestations of inflammatory bowel disease and affects up to 25% of patients. The treatment options for refractory disease were rather limited and ineffective until the arrival of biologic therapy in the last few years....
Autores principales: | Mohamed Said, Mohd Shahrir, Shaharir, Sazliyana, Rajalingham, Sakthiswary, Abdullah, Sheikh Anwar, bin Hassanudin, Aizan, Soon, Ngiu Chai, Shahid, Mohd Shahdan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398294/ https://www.ncbi.nlm.nih.gov/pubmed/22236863 http://dx.doi.org/10.1186/1752-1947-6-10 |
Ejemplares similares
-
Rheumatoid Arthritis: Refractory to Infliximab, a Tumor Necrosis Factor Inhibitor
por: Solehan, Hana Maizuliana bt, et al.
Publicado: (2011) -
Damage in the Multiethnic Malaysian Systemic Lupus Erythematosus (SLE) Cohort: Comparison with Other Cohorts Worldwide
por: Shaharir, Syahrul Sazliyana, et al.
Publicado: (2016) -
Frequency and Clinical Significance of Elevated IgG4 in Rheumatoid Arthritis: A Systematic Review
por: Sakthiswary, Rajalingham, et al.
Publicado: (2022) -
Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort
por: Shaharir, Syahrul Sazliyana, et al.
Publicado: (2021) -
The Clinical Significance of Interleukin–1 Receptor Antagonist +2018 Polymorphism in Rheumatoid Arthritis
por: Ismail, Endom, et al.
Publicado: (2016)